Abstract:Background: Osseous tumors of the foot and ankle are rarely encountered in general orthopaedic practice and represent only 3 % of osseous neoplasms. It can be difficult to distinguish between benign and malignant lesions, leading to misdiagnosis. Delays in diagnosis are the main cause of litigation in sarcoma of the extremities. Poor understanding of how sarcomas present in this region can lead to inappropriate initial procedures, limiting options for limb salvage and increasing rates of local recurrence. Our aim is to improve understanding of these rare tumors to reduce misdiagnosis and decrease the occurrence of inappropriate or unwarranted procedures. Methods: We retrospectively analysed a prospectively maintained database of 288 new referrals to the West of Scotland regional musculoskeletal oncology service for osseous lesions of the foot, ankle and lower leg over a 10-year period. An analysis of patient demographics, presentation, anatomical location, diagnosis, classification, management and outcomes was performed. Results: Of all new referrals, 52.4 % were diagnosed with primary benign osseous tumors, 8.7 % with primary malignant osseous tumors, 9.7 % with metastatic osseous lesions, and 29.2 % pseudotumors. The most common primary benign tumor in our population was osteoid osteoma (18.5 %), primary malignant tumor was osteosarcoma (32 %) and metastatic osseous lesions were from small cell lung cancer primary (14.3 %). In the foot and ankle, malignant bone tumors most commonly presented in the distal tibia and fibula (20 %). Rest pain was the most common symptom at presentation in all groups, followed by swelling. The average duration of symptoms was 5 months for malignant lesions before primary referral. Conclusion: Bone tumors in the foot and ankle remain a diagnostic challenge. We hope to have increased understanding of these rare lesions and have recommended a management protocol in order to reduce the number of inappropriate procedures performed, optimising clinical outcomes and reducing the cost of litigation to healthcare services. Level of evidence: Level III- Cross-sectional observational study.

An Aggressively Recurrent Squamous Cell Carcinoma of the Foot

“Diffuse Hot Pleura” in a Case of Recurrent Squamous Cell Carcinoma of the Foot

A simple sore can lead to limb amputation; metastatic squamous cell carcinoma of the sole in a 22-year-old man

Tumours of the foot: A 10 years retrospective analysis

Soft Tissue Tumors Of The Lower Leg, Foot And Ankle: A Cross-Sectional Observational Study Analysing 376 Cases

Cutaneous Squamous Cell Carcinoma: An Updated Review

Squamous Cell Carcinoma of the Nail Bed: A Case Report

Exophytic Squamous Cell Carcinoma of the Scalp: A Case Report

Palliative management of a recurrent destructive cutaneous squamous cell carcinoma of the scalp with brain exposure

Osseous tumors of the foot, ankle, and lower leg: a cross-sectional observational study analysing 288 cases

Rare localisation of a recurrent desmoid tumour of the foot: A case report and review of the literature

Misdiagnosis of Cutaneous Epithelioid Angiosarcoma as Diabetic Foot Ulcer: A Case Study

Recurrence rates after functional surgery versus amputation for nail squamous cell carcinoma not involving the bone: A systematic review

Aggressive cutaneous squamous cell carcinoma of the scalp

Management Approaches for High-Risk Cutaneous Squamous Cell Carcinoma with Perineural Invasion: An Updated Review

Management of Cutaneous Squamous Cell Carcinoma of the Scalp: The Role of Imaging and Therapeutic Approaches

METATARSAL OSTEOSARCOMA WITH LUNG METASTASIS

Squamous Cell Carcinoma Arising From Epidermal Cyst

Mutational Profiles of Cutaneous Squamous Cell Carcinomas with Different Patterns of Clinical Aggression from Head and Neck Regions

Distribution Patterns of Tumors and Tumor-Like Lesions of the Forefoot and Midfoot A 12.5-Year Study at a University Hospital

Cutaneous Squamous Cell Carcinoma: From Pathophysiology to Novel Therapeutic Approaches